Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulla M Wewer

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 6, 2003
The new frontier in muscular dystrophy research: booster genesEva Engvall, Ulla M Wewer
Plos One|June 5, 2012
Functional analysis of a breast cancer-associated mutation in the intracellular domain of the metalloprotease ADAM12Dorte Stautz, Ulla M Wewer, Marie Kveiborg
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|December 4, 2012
Regulation of ROCK activity in cancerMarie Morgan-Fisher, Ulla M Wewer, Atsuko Yoneda
Prenatal Diagnosis|June 6, 2006
Maternal serum ADAM12 levels in Down and Edwards' syndrome pregnancies at 9-12 weeks' gestationJennie Laigaard, Howard Cuckle, Ulla M Wewer, et al.
The International Journal of Biochemistry & Cell Biology|March 18, 2008
Cellular roles of ADAM12 in health and diseaseMarie Kveiborg, Reidar Albrechtsen, John R Couchman, et al.
Experimental Cell Research|October 19, 2010
Extracellular engagement of ADAM12 induces clusters of invadopodia with localized ectodomain shedding activityReidar Albrechtsen, Dorte Stautz, Archana Sanjay, et al.
Scientific Reports|June 25, 2016
The Phosphorylation and Distribution of Cortactin Downstream of Integrin α9β1 Affects Cancer Cell BehaviourAnette M Høye, John R Couchman, Ulla M Wewer, et al.
Mechanisms of Ageing and Development|August 9, 2011
Aging, longevity and healthLene Juel Rasmussen, Miriam Sander, Ulla M Wewer, et al.
Neuromuscular Disorders : NMD|October 4, 2005
ADAM12 overexpression does not improve outcome in mice with laminin alpha2-deficient muscular dystrophyLing T Guo, G Diane Shelton, Ulla M Wewer, et al.
The American Journal of Pathology|November 6, 2007
Transgenic overexpression of ADAM12 suppresses muscle regeneration and aggravates dystrophy in aged mdx miceLouise Helskov Jørgensen, Charlotte Harken Jensen, Ulla M Wewer, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 6, 2003
The new frontier in muscular dystrophy research: booster genesEva Engvall, Ulla M Wewer
Plos One|June 5, 2012
Functional analysis of a breast cancer-associated mutation in the intracellular domain of the metalloprotease ADAM12Dorte Stautz, Ulla M Wewer, Marie Kveiborg
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|December 4, 2012
Regulation of ROCK activity in cancerMarie Morgan-Fisher, Ulla M Wewer, Atsuko Yoneda
Prenatal Diagnosis|June 6, 2006
Maternal serum ADAM12 levels in Down and Edwards' syndrome pregnancies at 9-12 weeks' gestationJennie Laigaard, Howard Cuckle, Ulla M Wewer, et al.
The International Journal of Biochemistry & Cell Biology|March 18, 2008
Cellular roles of ADAM12 in health and diseaseMarie Kveiborg, Reidar Albrechtsen, John R Couchman, et al.
Experimental Cell Research|October 19, 2010
Extracellular engagement of ADAM12 induces clusters of invadopodia with localized ectodomain shedding activityReidar Albrechtsen, Dorte Stautz, Archana Sanjay, et al.
Scientific Reports|June 25, 2016
The Phosphorylation and Distribution of Cortactin Downstream of Integrin α9β1 Affects Cancer Cell BehaviourAnette M Høye, John R Couchman, Ulla M Wewer, et al.
Mechanisms of Ageing and Development|August 9, 2011
Aging, longevity and healthLene Juel Rasmussen, Miriam Sander, Ulla M Wewer, et al.
Neuromuscular Disorders : NMD|October 4, 2005
ADAM12 overexpression does not improve outcome in mice with laminin alpha2-deficient muscular dystrophyLing T Guo, G Diane Shelton, Ulla M Wewer, et al.
The American Journal of Pathology|November 6, 2007
Transgenic overexpression of ADAM12 suppresses muscle regeneration and aggravates dystrophy in aged mdx miceLouise Helskov Jørgensen, Charlotte Harken Jensen, Ulla M Wewer, et al.
Pageof 5